In a stunning move, the Department of Health and Human Services (HHS) has canceled 22 mRNA “vaccine” development contracts after experts confirmed they are “ineffective” and “prolong pandemics.”
The move will save taxpayers around $500 million and protect Americans from the risk of death and injuries caused by the injections.
It marks a major shift in vaccine strategy from the federal government.
The announcement, made Tuesday, follows a comprehensive internal review and a growing body of evidence indicating that the mRNA “vaccines,” widely promoted during the COVID-19 pandemic, fail to effectively combat upper respiratory infections like Covid and the flu.
HHS Secretary Robert F. Kennedy Jr. announced the change in a video statement, saying:
“We reviewed the science, listened to the experts, and acted.”
According to Kennedy, the mRNA “vaccines,” developed under the government’s Biomedical Advanced Research and Development Authority (BARDA), have proven ineffective against evolving respiratory viruses and fail to provide long-lasting protection.
In a video explaining the decision, Kennedy emphasized the serious risks posed by mRNA “vaccines,” pointing out that not only do they fail to protect against viruses like Covid and the flu, but they can also contribute to viral mutations.
This phenomenon, known as “antigenic shift,” occurs when vaccines inadvertently encourage new mutations, potentially prolonging pandemics as the virus constantly adapts to escape the vaccine’s effects.
Kennedy pointed specifically to the Omicron variant of COVID-19, which infected millions of individuals, including those who had received the mRNA injections.
“The [mRNA] vaccine [platform] paradoxically encourages new mutations and can actually prolong pandemics,” Kennedy noted, adding that the same risks apply to the flu virus as well.
“As the virus constantly mutates to escape the protective effects of the vaccine, millions of people, maybe even you or someone you know, caught the Omicron variant despite being vaccinated.
“That’s because a single mutation can make mRNA ‘vaccines’ ineffective.”
After concluding that mRNA shots prolong pandemics, encourage mutations, and are ineffective against respiratory viruses, Kennedy declared:
“mRNA technology poses more risk than benefits for these respiratory viruses.”
“That’s why we’re moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions,” Kennedy added.
WATCH:
The cancellation of these contracts does not signify the complete end of mRNA research, however.
Some final-stage contracts will continue to completion to honor previous taxpayer investments, and ongoing research at the National Institutes of Health (NIH) will not be affected.
But moving forward, the focus will shift toward “safer, broader vaccine strategies” that can better withstand viral mutations.
Kennedy announced that HHS will prioritize developing whole-virus vaccines and other innovative platforms that do not collapse when viruses mutate.
These new strategies aim to offer more durable solutions, which could prevent future health crises.
While Kennedy reiterated his support for “safe, effective vaccines” for Americans who choose them, he made it clear that the government’s future investments will be centered on better, more reliable vaccine solutions, marking a clear departure from the controversial mRNA technology.
As public distrust in the safety and efficacy of mRNA injections continues to grow, this decision by the HHS marks a significant shift away from the rushed vaccine strategies that have dominated the past few years.
For those Americans demanding accountability for public health decisions, this move offers a glimmer of hope that the government is finally acknowledging the limitations and dangers of mRNA-based “vaccines.”
Our comment section is restricted to members of the Slay News community only.
To join, create a free account HERE.
If you are already a member, log in HERE.